Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

WHAT'S NEW

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Apr 4 2022

Full Issue

Opioid Deaths Soar, Leaving States Scrambling For Solutions

Media outlets cover a worsening of the opioid epidemic, with AP noting the situation is now "even deadlier." Fentanyl contamination of illicit drugs is blamed. Separately, The Street and Stat cover news from Vertex Pharmaceuticals on the progress of a new non-opioid pain drug.

As the addiction and overdose crisis that has gripped the U.S. for two decades turns even deadlier, state governments are scrambling for ways to stem the destruction wrought by fentanyl and other synthetic opioids. In statehouses across the country, lawmakers have been considering and adopting laws on two fronts: reducing the risk to users and increasing the penalties for dealing fentanyl or mixing it with other drugs. Meanwhile, Republican state attorneys general are calling for more federal action, while some GOP governors are deploying National Guard units with a mission that includes stopping the flow of fentanyl from Mexico. (Mulvihill, 4/3)

The proportion of illicit pills laced with a dangerous opioid has continued to rise throughout the coronavirus pandemic, doubling between January 2018 and December 2021, according to a recently published study funded by the US National Institute on Drug Abuse. Using data on drug seizures collected by agencies across a nation-wide program, a team of researchers led by New York University epidemiologist Joseph J. Palamar evaluated the state of the opioid black market in the past three years. (McRae, 4/1)

During the coronavirus pandemic, drug overdose rates in America surged. In 2020, overdoses were up by 31% in the US, according to the Centers for Disease Control and Prevention (CDC). The death rate increased most dramatically among Black and Indigenous Americans – rising by 49% and 43% respectively in just one year. Experts say a large portion of this increase can be explained by the growing prevalence of fentanyl, a potent synthetic opioid. The reporter Erin McCormick has been investigating how the drug became so widespread in the US, and how its rise is rewriting the narrative of America’s opioid crisis. (Safi, McCormick and Mendoza, 4/3)

In other news about the opioid crisis —

Biotech Vertex Pharmaceuticals VRTX is getting closer on an approval for its pain pill that could serve as a replacement for opioids since trials showed greater improvements in pain relief. The company said on March 31 that it received positive results from two Phase 2 proof-of-concept studies that investigated treating patients with acute pain following abdominoplasty surgery or bunionectomy surgery with their drug known as VX-548. (Chang, 4/1)

A novel pain drug from Vertex Pharmaceuticals met its goals in two mid-stage trials, the company said Thursday, paving the way for pivotal trials that could lead to approval. The highest dose of the drug, a pill called VX-548, beat placebo at reducing patients’ pain within 48 hours of surgery, Vertex said. The company tested its medicine in two studies, enrolling about 550 patients who had just undergone either abdominoplasty or bunionectomy, giving them either placebo, the opioid treatment hydrocodone, or one of three dosage strengths of VX-548. Vertex now plans to advance VX-548 into pivotal studies in the second half of this year, pending permission from the Food and Drug Administration. (Garde, 3/31)

Opening statements are set in a lawsuit in West Virginia accusing several drugmakers of misrepresenting the risks and benefits of opioids. The bench trial starts Monday in Attorney General Patrick Morrisey’s lawsuit against Janssen Pharmaceuticals Inc., Teva Pharmaceuticals Inc., Allergan and their family of companies. (4/4)

In the basement of Madry Temple Church in New London, Margaret Lancaster, a health program coordinator at Ledge Light Health District, shows the pastor how to administer Narcan, the opioid overdose reversal treatment. In New Haven, at the Dixwell Avenue Congregational United Church of Christ, the Rev. Jerry Streets and local clinical staff are offering substance use disorder treatment. These alliances of frontline health care workers with trusted community leaders are addressing the alarming rise of substance use disorders by leveraging the cultural power of churches to reach people in need of help. (Jones, 4/3)

In related developments from around the world —

The Taliban on Sunday announced a ban on cultivating poppy flowers, which are used to make heroin, in a move seen as courting global approval while also putting farmers’ livelihoods at risk. The order also forbids the production, use and transit of other narcotics. (Beals, 4/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 18
  • Wednesday, June 17
  • Tuesday, June 16
  • Monday, June 15
  • Friday, June 12
  • Thursday, June 11
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF